Market by Type, Prescription, Therapeutic, Application, End-user, and Country | Forecast 2021-2028
Triton’s report established that the nasal spray market in the Middle
East and Africa is estimated to register growth at a compound annual growth
rate of 7.93% over the projected period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries considered for analysis in this market are:
• The United Arab Emirates
• Turkey
• South Africa
• Saudi Arabia
• Rest of Middle East &
Africa
In the region, allergic rhinitis is highly prevalent, with several
patients suffering from nasal congestion. The most common chronic respiratory
diseases in the region are asthma, lung cancer, COPD, and occupational lung
disease. Further, chronic rhinosinusitis has increased significantly across
African countries. This growth in respiratory and allergic diseases increases
the need for nasal sprays, thereby contributing to the growth of the nasal
spray market.
In the United Arab Emirates, indoor air pollution is among the biggest
health threats. As a result, chronic obstructive pulmonary disease has surged
over the past few years due to people being exposed to indoor air pollutants.
As per the Dubai Health Authority, approximately 20% of the country’s population
suffers from chronic sinusitis, with around 7% suffering from allergic
rhinitis. Hence, the rising respiratory diseases boost the overall growth of
the nasal spray market across the UAE.
Furthermore, the surge in allergic rhinitis, asthma, and other respiratory
conditions has increased the adoption of nasal sprays in Saudi Arabia. Besides,
there has been a substantial rise in chronic rhinosinusitis, which is likely to
add to the growth of the nasal spray market over the next few years.
Cipla Limited is a pharmaceutical company offering active pharmaceutical
ingredients and formulations across various therapeutic areas, such as women’s
health, children’s health, dermatology, infectious diseases, respiratory,
osteoporosis, and neurosciences. It also offers veterinary products, including
anti-thyroid, immunosuppressants, nutraceuticals, and feed additives for
various animals. Cipla has operations across various regions, including the
Middle East and Africa.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA NASAL SPRAY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON NASAL SPRAY MARKET
2.2. KEY
INSIGHTS
2.2.1. ALLERGY
TREATMENTS WITH NASAL SPRAYS
2.2.2. UTILIZING
NASAL SPRAY FOR DIABETES
2.2.3. ENDOMETRIOSIS
TREATMENT WITH NASAL SPRAYS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. EMERGING
INTRANASAL VACCINES FOR COVID-19
2.7.2. INCREASING
ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION
2.7.3. GROWING
USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES
2.8. MARKET
CHALLENGES
2.8.1. COMPLICATIONS
DUE TO EXCESS USE OF NASAL SPRAYS
2.9. MARKET
OPPORTUNITIES
2.9.1. APPLICATION
OF NASAL SPRAYS IN TREATING DEPRESSION
2.9.2. USING
INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
2.9.3. EMPLOYING
NASAL SPRAY AS A VACCINE
3. MIDDLE
EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY TYPE
3.1. DECONGESTION
NASAL SPRAY
3.2. STEROID
NASAL SPRAY
3.3. SALTWATER
SOLUTION/SALINE NASAL SPRAY
4. MIDDLE
EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION
4.1. OVER-THE-COUNTER
4.2. PRESCRIBED
5. MIDDLE
EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC
5.1. ANTIHISTAMINE
5.2. NASAL
STEROIDS
5.3. ANTICHOLINERGIC
5.4. MAST
CELL INHIBITOR
6. MIDDLE
EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY APPLICATION
6.1. NASAL
CONGESTION
6.2. ALLERGIC
AND NON-ALLERGIC RHINITIS
6.3. VACCINATION
6.4. CNS
DISORDERS
6.5. OTHER
APPLICATIONS
7. MIDDLE
EAST AND AFRICA NASAL SPRAY MARKET OUTLOOK - BY END-USER
7.1. HOME
CARE SETTING
7.2. ASC/CLINICS
7.3. PHARMACY
7.4. HOSPITAL
7.5. OTHER
END-USERS
8. MIDDLE
EAST AND AFRICA NASAL SPRAY MARKET – REGIONAL OUTLOOK
8.1. UNITED
ARAB EMIRATES
8.2. SAUDI
ARABIA
8.3. TURKEY
8.4. SOUTH
AFRICA
8.5. REST
OF MIDDLE EAST & AFRICA
9. COMPETITIVE
LANDSCAPE
9.1. AKORN
9.2. ALLERGAN
9.3. APOTEX
INC
9.4. BHARAT
BIOTECH
9.5. CATALENT
INC
9.6. CIPLA
LIMITED
9.7. GLAXOSMITHKLINE
9.8. JOHNSON
AND JOHNSON
9.9. NOVARTIS
INTERNATIONAL AG
9.10. PFIZER
INC
9.11. PROCTOR
AND GAMBLE CO
9.12. SANOTIZE
RESEARCH AND DEVELOPMENT
9.13. SUN
PHARMACEUTICALS INDUSTRIES LTD
9.14. TEVA PHARMACEUTICAL
INDUSTRIES LTD
9.15. VIATRIS
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 4: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 5: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 6: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE
3: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)
FIGURE
4: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)
FIGURE
5: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $
MILLION)
FIGURE
6: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)
FIGURE
7: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)
FIGURE
8: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)
FIGURE
9: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)
FIGURE
10: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)
FIGURE
11: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)
FIGURE
12: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)
FIGURE
13: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)
FIGURE
14: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE
15: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)
FIGURE
16: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $
MILLION)
FIGURE
17: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)
FIGURE
18: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE
19: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE
20: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE
21: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)
FIGURE
22: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)
FIGURE
23: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)
FIGURE
24: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)
FIGURE
25: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE
26: MIDDLE EAST AND AFRICA
NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE
27: UNITED ARAB EMIRATES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
28: SAUDI ARABIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
29: TURKEY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
30: SOUTH AFRICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
31: REST OF MIDDLE EAST & AFRICA NASAL SPRAY MARKET 2021-2028 (IN $
MILLION)